NeoRecormon er væsentligt mere effektivt end placebo (virkningsløs behandling) til at øge hæmoglobinniveauet hos patienter med forskellige former for anæmi, herunder patienter med nyresygdomme.
NeoRecormon was significantly more effective than placebo (dummy treatment) at increasing haemoglobin levels in patients with various types of anaemia, including those with kidney disease.